CliffBio
small molecule

MUCINEX DM

DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN

Loss of exclusivity—loss of exclusivity
CompanyRB HEALTH US LLC

Drug detail

Brand nameMUCINEX DM
Active ingredientDEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Strength30MG;600MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2004
Marketing statusOTC

More from RB HEALTH US LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MUCINEX DM patent cliff — loss of exclusivity — | CliffBio